What are the cost-effectiveness results of thrombolysis for acute ischemic stroke?
A number of studies have reported cost-effectiveness results of thrombolysis for acute ischemic stroke. These include the 2005 study by Demaerschalk et al., which found that utilization of intravenous tissue plasminogen activator (tPA) in the United States is cost-effective; Penaloza-Ramos et al., which found that optimizing acute stroke care services for thrombolysis was cost-effective; Tan et al., which found that thrombolysis within 4.5 hours of stroke was cost-effective; and Ganesalingam et al., which found that mechanical thrombectomy using stent retrievers was cost-effective. Health Quality Ontario also reported that mechanical thrombectomy for acute ischemic stroke is cost-effective.  